antithrombin

(redirected from Antithrombin III)
Also found in: Dictionary, Medical, Acronyms.
Related to Antithrombin III: antithrombin III test, protein C

antithrombin

[‚an·tē′thräm·bən]
(biochemistry)
A substance in blood plasma that inactivates thrombin.
Mentioned in ?
References in periodicals archive ?
Coagulation parameters (factor 2, 5, 8, 9, 10, 11, protein C and S, antithrombin III, active protein C resistance and homocysteine levels (2.
Fifty patients were included in the study which is not sufficient to establish antithrombin III as noninvasive marker in hepatitis C patients in our population of Pakistan.
Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma.
Prothrombin time (PT) and activated partial thromboplastin time (APTT) were normal; antithrombin III was not evaluated.
5) comprehensively investigated 10 patients for thrombophilia with protein C and protein S levels, platelet counts, fibrinogen levels, antiphospholipid antibody levels and antithrombin III levels.
Estrogens intervene at the vascular, platelet, and plasma levels as a function of hormonal variations in the menstrual cycle, increasing the aggregability of the platelets and thrombocytes, accelerating the formation of clots, and decreasing the amount of antithrombin III.
Rare thrombotic events during childhood usually take place due to deficiency of some factors inhibiting coagulation like Protein C (PC), Protein S (PS), and antithrombin III (1).
After discharge, the patient's coagulation studies, which consisted of lupus anticoagulant, protein C activity, protein S activity, antithrombin III activity, and homosistein levels, were normal.
The new product, which is a human antithrombin III concentrate, is indicated for the treatment of thrombosis associated with congenital antithrombin III deficiency as well as disseminated intravascular coagulation.
During warfarin anticoagulation, a hematologic evaluation yielded normal values for antithrombin III, lupus anticoagulants, prothrombin gene mutations, antinuclear antibodies, and anticardiolipin antibodies.